Consistent with this observation, our results demonstrated that miR-7-5p inhibited the expression of BRCA1 and Rad51 that was induced by doxorubicin in Dox-resistant SCLC cells by suppressing PARP1 expression (Fig. 4f). Here, RAD51 is linked to small cell lung carcinoma.